Iris Chan
Sanofi
4
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Anthony TC Chan, MD, FRCP
Department of Clinical Oncology, The Chinese University of Hong Kong
Shared therapeutic areas:
Wai Hon LAU, Dr
Department of Clinical Oncology, Queen Elizabeth Hospital
Shared therapeutic areas:
Abderahim (Rahim) Fandi, MD, PhD
Celgene
Shared therapeutic areas:
Allan Hildesheim, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yi Pan, MD, PhD
Guangdong Provincial People's Hospital
Shared therapeutic areas:
Dong-Ping Chen, MD, PhD
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Shared therapeutic areas:
ping liu, doctor
Second Xiangya Hospital of Central South University
Shared therapeutic areas:
Matthew Parliament, MD
Cross Cancer Institute
Shared therapeutic areas:
Ying Sun, Ph.D.
Sun Yat-sen University
Shared therapeutic areas:
Ming-Yuan Chen, MD,PhD
Sun Yat-Sen University Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Taxotere + Cisplatin in Nasopharyngeal Carcinoma
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Leflunomide in Systemic Lupus Erythematosus
All 4 trials loaded